These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6848728)

  • 1. Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization.
    Chudwin DS; Wara DW; Matthay KK; Caulfield MH; Schiffmann G; Mentzer WC; Ammann AJ
    J Pediatr; 1983 Jan; 102(1):51-4. PubMed ID: 6848728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.
    Nowak-Wegrzyn A; Winkelstein JA; Swift AJ; Lederman HM
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):788-93. PubMed ID: 10973456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of pneumococcal bacteremia by immunization with type 6 pneumococcal capsular polysaccharide vaccine in splenectomized rats.
    Iinuma H; Okinaga K
    J Infect Dis; 1989 Jul; 160(1):66-75. PubMed ID: 2732517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis.
    Bjornson AB; Falletta JM; Verter JI; Buchanan GR; Miller ST; Pegelow CH; Iyer RV; Johnstone HS; DeBaun MR; Wethers DL; Wang WC; Woods GM; Holbrook CT; Becton DL; Kinney TR; Reaman GH; Kalinyak K; Grossman NJ; Vichinsky E; Reid CD
    J Pediatr; 1996 Dec; 129(6):828-35. PubMed ID: 8969724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.
    Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC
    N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
    Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
    Kaplan J; Sarnaik S; Schiffman G
    Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response.
    Barrett DJ; Ammann AJ
    Rev Infect Dis; 1981; 3 Suppl():S179-82. PubMed ID: 6169129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic and antibody responses to pneumococcal polysaccharide types 6A, 19F and 23F after vaccination of immunocompromised patients.
    Braconier JH; Pedersen FK; Odeberg H; Rosén C
    Scand J Infect Dis; 1984; 16(2):161-7. PubMed ID: 6740247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic function.
    Ammann AJ
    Am J Pediatr Hematol Oncol; 1982; 4(3):301-6. PubMed ID: 7149168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.
    Braconier JH; Myhre EB; Odeberg H
    Eur J Clin Microbiol; 1983 Oct; 2(5):453-8. PubMed ID: 6641723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
    De Montalembert M; Abboud MR; Fiquet A; Inati A; Lebensburger JD; Kaddah N; Mokhtar G; Piga A; Halasa N; Inusa B; Rees DC; Heath PT; Telfer P; Driscoll C; Al Hajjar S; Tozzi A; Jiang Q; Emini EA; Gruber WC; Gurtman A; Scott DA
    Pediatr Blood Cancer; 2015 Aug; 62(8):1427-36. PubMed ID: 25810327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.
    Weintrub PS; Schiffman G; Addiego JE; Matthay KK; Vichinsky E; Johnson R; Lubin B; Mentzer WC; Ammann AJ
    J Pediatr; 1984 Aug; 105(2):261-3. PubMed ID: 6747758
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary: infections in sickle cell and SC disease.
    Powars D; Overturf GD; Wilkins J
    J Pediatr; 1983 Aug; 103(2):242-4. PubMed ID: 6875716
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
    Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
    J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls.
    Bortolussi R; Marrie TJ; Cunningham J; Schiffman G
    Infect Immun; 1981 Oct; 34(1):20-5. PubMed ID: 7028628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease.
    Vernacchio L; Neufeld EJ; MacDonald K; Kurth S; Murakami S; Hohne C; King M; Molrine D
    J Pediatr; 1998 Aug; 133(2):275-8. PubMed ID: 9709721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia.
    Chintu C; Gupta K; Osborne C; Masona JM
    Med J Zambia; 1983 Jul; 17(3):73-6. PubMed ID: 6679155
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
    J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.